ZBH

SEC source: 0001062993-23-006280 · form4.xml · derivative · entry 1

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,256

Underlying: Common Stock · 4,256 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

SEC source: 0001062993-23-006058 · form4.xml · derivative · entry 3

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186

Underlying: Common Stock · 187 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F5 · derivative.exercise_date: 187 of the RSUs vested on March 2, 2023 and the remaining 186 RSUs vest on March 2, 2024.

F5 · derivative.expiration_date: 187 of the RSUs vested on March 2, 2023 and the remaining 186 RSUs vest on March 2, 2024.

SEC source: 0001062993-23-006058 · form4.xml · nonDerivative · entry 2

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 364

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.

SEC source: 0001062993-23-006058 · form4.xml · nonDerivative · entry 1

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSU's) reflects the adjustment that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company's") spinoff of ZimVie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 2 shares acquired pursuant to dividend reinvestment between April 27, 2022 and January 27, 2023.

SEC source: 0001062993-23-004635 · form4.xml · derivative · entry 2

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,423 shares

Expires 2023-02-21

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

SEC source: 0001062993-23-004635 · form4.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,527

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 268 shares acquired under the Company's Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 2, 2023.

SEC source: 0001062993-23-004633 · form4.xml · derivative · entry 3

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,011 shares

Expires 2023-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

SEC source: 0001062993-23-004633 · form4.xml · nonDerivative · entry 2

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,519

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.

SEC source: 0001062993-23-004633 · form4.xml · nonDerivative · entry 1

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,147

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 65 shares acquired under the Company's Employee Stock Purchase Plan on December 30, 2022.

SEC source: 0001062993-23-004629 · form4.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,132 shares

Expires 2023-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F1 · shares: This number of restricted stock units ("RSU's") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

SEC source: 0001062993-23-004629 · form4.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,797

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.

SEC source: 0001062993-23-004629 · form4.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSU's") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 194 shares acquired under the Company's Employee Stock Purchase Plan June 30, 2022.

SEC source: 0001062993-23-004627 · form4.xml · derivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,195 shares

Expires 2023-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

SEC source: 0001062993-23-004627 · form4.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,671

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.

SEC source: 0001062993-23-004627 · form4.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,233

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 158 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through January 27, 2023.

SEC source: 0001062993-23-004623 · form4.xml · derivative · entry 3

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,046 shares

Expires 2023-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

SEC source: 0001062993-23-004623 · form4.xml · nonDerivative · entry 2

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,503

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.

SEC source: 0001062993-23-004623 · form4.xml · nonDerivative · entry 1

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,864

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 194 shares acquired under the Company's Employee Stock Purchase Plan on June 30, 2022.

SEC source: 0001062993-23-004620 · form4.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,860 shares

Expires 2023-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

SEC source: 0001062993-23-004620 · form4.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,892

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.

SEC source: 0001062993-23-004620 · form4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 206 shares acquired under the Company's Employee Stock Purchase Plan on June 30, 2022 and December 30, 2022.

SEC source: 0001062993-23-000264 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,156.977

Underlying: Common Stock · 255.966 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 63.383 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-000271 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,531.534

Underlying: Common Stock · 216.587 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 21.865 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-000270 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,885.887

Underlying: Common Stock · 108.293 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 3.768 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-000268 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,019.082

Underlying: Common Stock · 108.293 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 8.29 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-000266 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,961.269

Underlying: Common Stock · 216.587 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 12.177 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-000263 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,422.714

Underlying: Common Stock · 265.811 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 53.327 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-000261 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,735.026

Underlying: Common Stock · 246.122 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 24.354 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-000260 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,186.743

Underlying: Common Stock · 246.122 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 35.91 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-000259 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,254.054

Underlying: Common Stock · 295.346 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 33.829 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-22-023943 · form4.xml · derivative · entry 4

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,045

Underlying: Common Stock · 11,522 shares

Expires 2023-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022.

F5 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on March 18, 2014.

SEC source: 0001062993-22-023943 · form4.xml · nonDerivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,880

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022.

F4 · price: Reflects the weighted average price of 1,063 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on December 13, 2022 with sale prices ranging from $129.02 to $129.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price.

SEC source: 0001062993-22-023943 · form4.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,943

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022.

F3 · price: Reflects the weighted average price of 10,459 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on December 13, 2022 with sale prices ranging from $128.00 to 128.98 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price.

SEC source: 0001062993-22-023943 · form4.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,402

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022.

F2 · balance_after: Includes 341 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan and pursuant to dividend reinvestment between April 27, 2022 and October 31, 2022.

SEC source: 0001062993-22-023419 · form4.xml · derivative · entry 9

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,571 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022.

F4 · derivative.expiration_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022.

SEC source: 0001062993-22-023419 · form4.xml · derivative · entry 8

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 954 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022.

F4 · derivative.expiration_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022.

SEC source: 0001062993-22-023419 · form4.xml · derivative · entry 7

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,123 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022.

F4 · derivative.expiration_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022.

SEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 6

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,072

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 5

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,941

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 4

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,370

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 3

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,832

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 2

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,878

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 1

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 203 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan since December 7, 2021.

SEC source: 0001062993-22-020324 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,924.879

Underlying: Common Stock · 352.344 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 33.167 phantom stock units accrued on July 29, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-22-020333 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,293.082

Underlying: Common Stock · 258.386 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 21.303 phantom stock units accrued on July 29, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-22-020331 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,732.505

Underlying: Common Stock · 258.386 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 11.362 phantom stock units accrued on July 29, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-22-020330 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,837.628

Underlying: Common Stock · 305.365 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 63.701 phantom stock units accrued on July 29, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-22-020329 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,773.826

Underlying: Common Stock · 129.193 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 3.300 phantom stock units accrued on July 29, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-22-020328 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,902.499

Underlying: Common Stock · 129.193 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 7.940 phantom stock units accrued on July 29, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-22-020327 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,103.576

Underlying: Common Stock · 317.11 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 53.330 phantom stock units accrued on July 29, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.